MMP9 and rheumatoid arthritis: In particular, MMP9, which is an important predictor of RA disease activity, is the most important protease leading to cartilage degradation, is a systemic inflammatory marker, and can be used as an indicator of synovial damage and prognosis in RA patients 90.